An official website of the United States government
Here's how you know
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.
As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
the contents by NLM or the National Institutes of Health.
Learn more:
PMC Disclaimer
|
PMC Copyright Notice
Correction: A Nationwide Study of Norwegian Patients with Hereditary Angioedema with C1 Inhibitor Deficiency Identified Six Novel Mutations in SERPING1
This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
There are errors in the author affiliations. The affiliations should appear as shown here:
Irene Johnsrud1,2 Mari Ann Kulseth3, Olaug Kristin Rødningen3, Linn Landrø1,2, Per Helsing1, Erik Waage Nielsen 2,4,5,6, Ketil Heimdal3
1 Department of Dermatology, Oslo University Hospital, Rikshospitalet, N 0027 Oslo, Norway 2 Institute of Clinical Medicine, University of Oslo, N 0316 Oslo, Norway 3 Department of Medical Genetics, Oslo University Hospital, N 0027 Oslo, Norway 4 Department of Anesthesiology, Nordland Hospital, N 8092 Bodø, Norway 5 Faculty of Health Sciences, University of Tromsø, 9037 Tromsø, Norway 6 University of Nordland, Faculty of Professional Studies, 8049 Bodø, Norway
The order of S1 and S2 figs are switched. Please see the complete, correct S1 and S2 Figs here.
Supporting Information
S1 Fig. Distribution of disease causing mutations in SERPING1 identified in the Norwegian families with hereditary angioedema with C1 inhibitor deficiency.
a) SERPING1 mRNA exon 3 to 8. Location of primers used for RT-PCR, are indicated with arrows. The splice site variant (c.889+3A>T) and the polymorphism in exon 8 (c.1438G>A) are shown. b) RT-PCR with primers in exon 3 and 6 (black arrows). The electropherogram shows a mix of two transcripts, one normal and one that lacks exon 5. c) Specific amplification of normal transcript using primers in exon 5 and 8 (grey arrows). The electropherogram of the reverse sequence shows that the majority of the normal transcripts have a G (reverse sequence C) in position 1438, thus indicating monoallelic expression of normal transcript.
1.
Johnsrud I, Kulseth MA, Rødningen OK, Landrø L, Helsing P, Waage Nielsen E, et al. (2015) A Nationwide Study of Norwegian Patients with Hereditary Angioedema with C1 Inhibitor Deficiency Identified Six Novel Mutations in SERPING1
. PLoS ONE
10(7): e0131637
doi: 10.1371/journal.pone.0131637
[DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
S1 Fig. Distribution of disease causing mutations in SERPING1 identified in the Norwegian families with hereditary angioedema with C1 inhibitor deficiency.
a) SERPING1 mRNA exon 3 to 8. Location of primers used for RT-PCR, are indicated with arrows. The splice site variant (c.889+3A>T) and the polymorphism in exon 8 (c.1438G>A) are shown. b) RT-PCR with primers in exon 3 and 6 (black arrows). The electropherogram shows a mix of two transcripts, one normal and one that lacks exon 5. c) Specific amplification of normal transcript using primers in exon 5 and 8 (grey arrows). The electropherogram of the reverse sequence shows that the majority of the normal transcripts have a G (reverse sequence C) in position 1438, thus indicating monoallelic expression of normal transcript.